CODX CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm's Attorneys, Securities Class Action PendingNewsfile Corp • 09/07/22
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODXNewsfile Corp • 09/03/22
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODXPRNewsWire • 09/01/22
Co-Diagnostics, Inc. to Host Booth at Medical Fair Asia 2022 in Singapore on Aug 31-Sep 2PRNewsWire • 08/31/22
TOP RANKED ROSEN LAW FIRM Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODXNewsfile Corp • 08/30/22
CO-DIAGNOSTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Co-Diagnostics, Inc.PRNewsWire • 08/30/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CODXBusiness Wire • 08/29/22
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Co-Diagnostics, Inc. (CODX) Investors of Class Action and to Actively ParticipateBusiness Wire • 08/26/22
CODX ALERT: Hagens Berman, National Trial Attorneys, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm's Attorneys, Securities Class Action FiledNewsfile Corp • 08/26/22
CODX Stock News: Robbins LLP is Investigating Co-Diagnostics, Inc. (CODX) on Behalf of ShareholdersBusiness Wire • 08/24/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Co-Diagnostics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NYSE: CODX)PRNewsWire • 08/24/22
CODX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 17, 2022 in the Class Action Filed on Behalf of Co-Diagnostics, Inc. Limited ShareholdersNewsfile Corp • 08/23/22
ROSEN, A TOP RANKED LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODXPRNewsWire • 08/23/22
Co-Diagnostics, Inc. to Present at 14th Next Generation Dx Summit in Washington, D.C.PRNewsWire • 08/22/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm's Attorneys, Securities Fraud Class Action FiledPRNewsWire • 08/19/22
CO-DX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Co-Diagnostics, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 08/18/22
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Co-Diagnostics, Inc. (CODX)Business Wire • 08/17/22
EQUITY ALERT: Rosen Law Firm Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CODXBusiness Wire • 08/16/22
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
CoDiagnostics, Inc. (CODX) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/11/22
Co-Diagnostics ends 2Q with $96M in cash, expands infectious disease testing menu to include monkeypoxProactive Investors • 08/11/22
CO-DIAGNOSTICS, INC. ANNOUNCES FIRST QUARTER 2022 EARNINGS RELEASE DATE AND WEBCASTPRNewsWire • 08/02/22